The cellular mechanisms involved in chronic inflammatory processes are poorly understood. This is especially true for the role of macrophages, which figure prominently in the inflammatory response. Two proteins, MRP8 and MRP14, which are expressed in infiltrate macrophages during inflammatory reactions but not in normal tissue macrophages, have been characterized. Here we report that MRP8 and MRP14 mRNAs are specifically expressed in human cells of myeloid origin and that their expression is regulated during monocyte-macrophage and granulocyte differentiation. To initiate the analysis of cis-acting elements governing the tissue-specific expression of the MRP genes, we cloned the human genes encoding MRP8 and MRP14. Both genes contain three exons, are single copy, and have a strikingly similar organization. Cells of myeloid origin composing the monocyte-macrophage and granulocyte lineages exercise a wide range of functions in the physiology of the immune system. The regulation of the many accessory and effector roles of these cells is complex and subject to control by a variety of lymphokines and cytokines. Macrophage migration inhibitory factor is one such factor and is thought to play an important role in the differentiation of mononuclear phagocytes (34).
Cells of myeloid origin composing the monocyte-macrophage and granulocyte lineages exercise a wide range of functions in the physiology of the immune system. The regulation of the many accessory and effector roles of these cells is complex and subject to control by a variety of lymphokines and cytokines. Macrophage migration inhibitory factor is one such factor and is thought to play an important role in the differentiation of mononuclear phagocytes (34) .
Using a monoclonal antibody directed against human macrophage migration inhibitory factor, two novel proteins were isolated and purified as part of a complex (4) . These are referred to as MRP8 and MRP14 (migration inhibitory factorrelated proteins) (41) . The cloning and expression of human MRP8 and MRP14 cDNAs have allowed studies on the biological properties of these proteins to be done (41) . Experiments employing immunohistochemical techniques have shown that these proteins are expressed exclusively in cells of myeloid origin. In peripheral blood they appear in monocytes and granulocytes (G. Zwadlo, J. Brueggen, G. Gerhards, R. Schlegel, and C. Sorg, Clin. Exp. Immunol., in press). In infiltrate of acute inflammatory tissues, MRP14 is expressed in certain subsets of macrophages, whereas MRP8 is absent. In contrast, both MRP8 and MRP14 are expressed in chronic inflammatory lesions, such as those observed in primary chronic polyarthritis. In resident macrophages of different tissues, neither of the proteins is detectable (Zwadlo et al., in press). Recently, it has been reported that MRP8 is present in elevated quantities in blood serum of patients suffering from cystic fibrosis (10) .
The present study deals with the regulation of the genes encoding MRP8 and MRP14. Their expression is shown to be restricted to human blood monocytes and human cell lines of myeloid origin, the promyelocytic leukemia cell line HL60 (7) , and the promonocytic leukemia cell line U937 (46) . We further demonstrate that expression of both MRP8 and MRP14 mRNAs was enhanced or diminished during the induction of differentiation of HL60 cells depending on the inducing agent. The complete human genes for MRP8 and MRP14 were cloned and characterized, including the flanking transcriptional regulatory sequences. Furthermore, using a transient chloramphenicol acetyltransferase (CAT) assay in HL60 cells, we demonstrated that the regions responsible for the regulated expression of MRP8 and MRP14 are located in the cloned genes. The polypeptide sequences of MRP8 and MRP14 were compared with published data for other proteins, and it was found that the MRP proteins share extensive homology with small calcium-binding protein sequences such as S100ox (25) , S100, (23, 24, 27, 30) , intestinal calcium-binding protein (ICaBP) (22, 32, 47) , calcyclin (2A9) (5) , and P11 (15, 17) . We suggest that these closely related proteins belong to a new subfamily of calcium-binding proteins. Our studies provide a framework for the study of regulatory cis-acting elements activated during cell differentiation in the myeloid pathway.
MATERIALS AND METHODS Cells. Human blood monocytes were isolated from healthy blood donors and successively purified on two Percoll (Pharmacia, Inc., Piscataway, N.J.) gradients according to the protocol of the manufacturer. One sample of monocytes was isolated and further purified in the presence of 5 ,ug of actinomycin D (Serva Heidelberg, Federal Republic of Germany) per ml to block transcription during the procedure. The following human cell lines were used in the study: HL60 (promyelocytic leukemia), U937 (promonocytic leukemia), Namalwa (B-cell lymphoma), and MOLT-4 (T-cell leukemia). These cells were grown in RPMI = 1640 medium supplemented with 10% fetal calf serum and antibiotics. (42) were hybridized to the digested genomic DNA by standard methods. The MRP8 cDNA probe was a 369-base-pair (bp) PvulII-PstI fragment derived from pMRP8-3 containing a complete MRP8 cDNA (41) . The MRP14 cDNA probe was a 364-bp DraIII-AmlaI fragment derived from pMRP14-10 containing the MRP14 cDNA (41) . After hybridization, membranes were washed successively at low stringency (6x SSC, 65°C) and at high stringency (0.1X SSC, 65°C).
Cloning and sequencing of MRP8 and MRP14 genes. A human fetal liver DNA library established in the X Charon 4A bacteriophage vector (31) was screened by plaque hybridization by the method of Benton and Davis (2) . With the MRP8 cDNA probe, six positively hybridizing clones were identified from 6 x 105 independent phage plaques. Southern blot analysis of the purified DNA from clones XMRP8-1 to -6 showed that all six recombinant phage contained the complete MRP8 gene. A 5-kb HpaII DNA fragment encompassing the MRP8 gene was subcloned from phage XMRP8-3 into pBR322 linearized with ClaI (pBRMRP8). A HindIII-EcoRI fragment containing the MRP8 gene was similarly subcloned in HindIII-EcoRI-cut pUC8 (pUCMRP8). With the MRP14 cDNA probe, four positive phage plaques were identified and plaque purified. One clone, XMRP14-2, containing the complete MRP14 gene on a 6-kb PstI DNA fragment was subcloned into the PstI site of pUC9 (pUCMRP14). The strategy used for sequencing the MRP8 and MRP14 genes in a plasmid subclone is depicted in Fig. 3 . . . ization to the control cDNA probe EF4, the mouse protein synthesis initiation factor 4A, revealed a transcript of 2 kb in all cells (39) .
Association of regulation of MRP8 and MRP14 expression with differentiation of HL60 leukemia cells. To follow the temporal pattern of expression of the MRP8 and MRP14 mRNA in a myeloid cell line during differentiation, we analyzed RNA from the HL60 cell line. This cell line is a model system for myeloid differentiation. Proliferating HL60 cells can be stimulated to terminally differentiate into nonproliferating monocytic (36) or granulocytic (8) lineages by treatment with PMA or DMSO, respectively. Within 24 h of induction of HL60 cell differentiation with PMA, the levels of MRP8 and MRP14 mRNA essentially disappear (Fig. 1D ). In contrast, with DMSO treatment, a marked expression of both MRP mRNAs was observed after 24 h. For MRP8, this was concomitant with the progressive appearance of a larger mRNA transcript, approximately 1 kb in length (Fig. 1C) 2A) . Similarly, placental DNA restricted with BamHI and PstI also revealed a single DNA fragment hybridizing with the MRP14 cDNA probe, whereas two DNA fragments were detected after cleavage with HindIlI and EcoRI (Fig. 2B) . No additional bands of hybridization were detected even under low-stringency conditions (data not shown). To isolate the two MRP genes, we screened a human liver DNA library with MRP8 and MRP14 cDNA probes. Several overlapping clones, as determined by restriction analysis (data not shown), were isolated. For sequence analysis, a 5-kb HpaII DNA fragment containing the MRP8 gene and a 4.2-kb PstI DNA fragment encompassing the MRP14 gene were subcloned (Fig. 3) . The entire sequences of the MRP8 and MRP14 genes including the introns and proximal 5'-and 3'-flanking regions are shown in Fig. 4 3 . Genomic organization and DNA-sequencing strategy of the human MRP8 and MRP14 genes. The black areas stand for the coding regions, and the boxed-in regions show the untranslated parts of the genes. The arrows point to the sequencing direction and end when the sequence is not clearly readable.
consensus DNA motif involved in lariat structure formation (5'-CTPuAPy-3') for splicing (43) . A stretch of GTs and Ts is found 15 to 20 bp downstream of the poly(A) addition site ( Fig. 4 and 5) . Such DNA sequences were recently shown to be essential for the formation of genuine 3' mRNA termini (16; for a review, see reference 3). The DNA sequences of the exons were identical to the cDNA sequences described before (41) .
Alignment of the MRP DNA sequences 5' of the initiation site of transcription revealed several sequence motifs conserved in MRP8 and MRP14. The promoter region of each of the MRP genes contains a sequence at -29 that fulfills the criteria for a TATAAA box as found in many polymerase II promoters as well as a CAAT box at position -92 in MRP8 and -76 in MRP14. The transcription initiation site, numbered + 1 in Fig. 4 and 5, was determined by primer extension (data not shown).
Furthermore, the flanking sequences include an 11-bp stretch of homology which could be involved in the tissuespecific regulation of these genes. The 11-bp sequence reads 5'-AGGAGCTGCCT-3' and is placed immediately adjacent to, but on opposite sides of, the TATA box when both genes are compared. Other more inconspicuous stretches of DNA might be involved in the regulation of some of the clearly different patterns of expression of the two genes. First, the MRP8 gene is flanked by a pair of 325-bp inverted repeats (Fig. 4) . These share 78% sequence homology, but the copy at the 3' end of the gene is interrupted by a 300-bp element that belongs to the AluI family (26) . The inverted repeat bears no significant homology with other known sequences in the EMBL DNA libraries. A second, 16-bp inverted repeat, 5'-TGAGTGCATGCACTCA-3', was identified at position -400 in the MRP8 gene (Fig. 4) . This repeat contains an octamer, (TGCA)2, which is also found as four tandemly arranged copies in the XUlb small nuclear RNA gene of Xenopus laevis (29) . Its sequence is reminiscent of a transcriptional enhancer since it is composed of multiple alternate Pu and Py, an arrangement which is expected to fold into a Z-DNA conformation (38, 40) . Finally, another potential regulatory DNA sequence is located 380 bp downstream of the 3' end of the MRP8 mRNA (Fig. 4) . This 32-bp sequence contains mostly (GT),, yielding a potential Z-DNA structure.
As shown overlined in the MRP14 gene promoter (Fig. 5) , there is a putative SP1 transcription factor-binding site (5'-CCGCCC-3') at position -130. In the mRNA 3' untranslated region, a stretch of DNA contains several direct repeats, 5'-GGCCAC-3' (overlined in Fig. 5 ). This motif is also found upstream of the TATA box in the interleukin-la gene promoter (14) and was described as a potential transcriptional regulatory signal because of its homology with the adenovirus type 2 major late promoter sequence. This tandem array of direct repeats may explain the failure to isolate full-length cDNAs clones: five independent cDNA isolates end in the region containing these direct repeats (41) . As a consequence, the 3' end of the MRP14 mRNA was placed 20 bp downstream of the poly(A) addition site, as for the MRP8 gene.
MRP8 and MRP14 are both members of a new family of small calcium-binding proteins. A computer-assisted protein sequence comparison of MRP8 and MRP14 peptides with the protein data base of the National Biomedical Research Foundation (United States) revealed strong homologies between MRP8 and MRP14 peptides and small calcium-binding proteins including S100oa, S100,B, ICaBP, calcyclin (2A9), and Pll. The homologies are concentrated in the calciumbinding domains of these proteins (Fig. 6) . These domains are known as EF hands or calcium-binding fingers and consist of two very characteristic a-helices interrupted by a turn (28) , the calcium ion being bound to the turn by oxygen-containing residues. This motif is repeated two to four times in these calcium-binding proteins, and it is believed that the proteins have evolved from a common ancestor (1, 9 variant EF hand), and the other in the C terminal part of the proteins is 28 amino acids long (a normal EF hand) (48) . MRP8 protein is closely related to S1OOa. There are 32 residues identically aligned with respect to the sequence of the two proteins in Fig. 6 , and the two additional residues of the variant EF hand in MRP8, serine and histidine, are aligned with respect to the sequence of the variant calciumbinding site of SlOOa. On the other hand, MRP14 is closely related to S10013. There are 34 amino acids aligned with respect to the sequences of the two proteins in Fig. 6 . The two additional amino acids of the variant EF hand of MRP14 are serine and aspartic acid.
Transient expression of pUCMRP8dCAT and pUCMRP14
dCAT in the promyelocytic cell line HL60 but not in the epithelial cell line L132. A transient expression assay was devised to investigate the tissue-specific regulatory elements responsible for the induction or inhibition of MRP gene expression after differentiation in the leukemia HL60 cell. For both genes, we constructed two similar clones containing exon 1 and a large part of the untranslated region of exon 2 ( Fig. 3 transfections in both HL60 and L132 cells. In each case, CAT expression was assayed relative to that of cells transfected with a pCMVCAT control plasmid. The cytomegalovirus promoter-enhancer routinely expressed high levels of CAT activity in both cell types. Both pUCMRP8dCAT and pUCMRP14dCAT expressed CAT activity in HL60 cells, and these levels increased three-to fourfold after induction by DMSO treatment (Fig. 7, lanes 3 to 6) . This higher level of CAT activity was not observed for the pCMVCAT construct (lanes 1 and 2) . In L132 cells, on the other hand, only the pCMVCAT vector generated a high level of CAT activity, while the pUCMRPdCAT constructs failed to yield detectable activity. From these results, we conclude that the regulatory cis-acting elements responsible for the regulated expression of the MRP genes in HL60 cells are present in the cloned MRP genes. DISCUSSION To study the tissue-specific regulation of the MRP8 and MRP14 genes, we analyzed mRNA derived from different VOL. 8, 1988 2407 (28) . The vertical arrow indicates the position where introns interrupt the coding sequences, except for the calcyclin (2A9) gene (11) , in which it must be shifted one amino acid to the right. 0 stands for residues EDQNST (oxygen-containing residues), L stands for residues LVIFM (hydrophobic amino acids), and + stands for inserted amino acids. Identical amino acids are shown on black areas, and functionally homologous amino acids are boxed in. Hu, Human; Bo, bovine; Ra, rat; and Po, porcine. blood cells because MRP8 and MRP14 mRNA expression observed in these leukemia cell lines is in contradiction with the high level of expression of the MRP8 and MRP14 proteins observed in normal blood monocytes and granulocytes (41) . To determine whether this apparent contradiction was a result of using the leukemia cell lines, we initiated the analysis of the mRNA levels in freshly isolated human blood monocytes. RNA samples from those cells revealed high levels of MRP8 and MRP14 mRNAs. This result suggests that the regulation of the mRNA levels in U937 and in HL60 induced by PMA is different from that observed in normal blood monocytes.
To further study this complex mechanism of MRP regulation during myeloid cell differentiation, we cloned the genes encoding human MRP8 and MRP14. MRP8 and MRP14 have a similar genomic organization: both are small genes containing three exons of approximately equivalent length and coding capacities (Fig. 3) . While this manuscript was in preparation, the genomic structure of calcyclin (2A9) was described (11) and shown to be very similar to that of the MRP genes. In all cases, exon 1 is untranslated and exon 2 and 3 each delimit an entire calcium-binding domain. As presented in Fig. 6 , MRP8 and MRP14 are calcium-binding proteins, closely related in structure to S100a, S1001, ICaBP, calcyclin (2A9), and P11. The MRP8 and MRP14 peptides contain two calcium-binding sites or EF hands; the normal EF hand with 28 amino acids resides in the Cterminal part of the protein and the variant EF hand with 30 amino acids is located in the N-terminal part of the protein (48) . Experiments have shown that MRP8 and MRP14 proteins immobilized on Western blots (immunoblots) indeed bind 45Ca2+ (J. Lucas et al., manuscript in preparation; data provided to the reviewer).
The linker sequences joining the two EF hands in all these proteins differ markedly. Since these linker regions are seemingly free to evolve, compared with the very conserved nature of calcium-binding domains, it was proposed that sequence divergence in the linkers results from the unique functions of these proteins and may be related to their specific interactions in different tissues (48) . The C-terminal segment of MRP14 may similarly have some special function unique to this molecule since it is unusually long in comparison with other members of the family (Fig. 6) .
At the gene level, we identified an intron in both the MRP8 and MRP14 genes located in the middle of the linker region. It is possible that this intron has had a role in the evolution of this protein family. The alignment of the EF hands in most of the protein sequences shown in Fig. 6 requires a gap or a deletion of amino acids in the region of this intron. Further, TISSUE-SPECIFIC Ca2+-BINDING PROTEIN GENE EXPRESSION exons 2 and 3 of MRP8 and MRP14 each encode a complete calcium-binding domain. The same is true for calcyclin (2A9) (11) . In contrast, the large calcium-binding proteins such as calmodulin or parvalbumin (21) have introns which interrupt their calcium-binding domains. It is tempting to speculate that the presently uncharacterized genes encoding SlOOa, S10013, P11, and ICaBP will have genomic structures similar to those of the MRP8, MRP14, and calcyclin genes (see vertical arrow, Fig. 6 ) and therefore that all these closely related proteins belong to a new subfamily of calciumbinding proteins.
The promyelocytic cell line HL60 and the epithelial cell line L132 were transfected with the MRP genes fused with the cat gene. The two chimeric constructs pUCMRP8dCAT and pUCMRP14dCAT expressed CAT activity only in the HL60 cells. Furthermore, upon DMSO induction this activity was enhanced, whereas upon PMA induction no CAT activity was detected (data not shown). The mechanism of regulation seems to be specific for these two genes because the expression of CAT activity from the cytomegalovirus promoter-cat construct (pCMVCAT) was not affected. These results suggest that we cloned the tissue-specific regions which permit the MRP8 and MRP14 genes to be expressed in the promyelocytic HL60 cell. We also conclude that the cis-acting elements which enhance or inhibit MRP8 and MRP14 gene expression during HL60 differentiation into a granulocytic or monocytic lineage, respectively, are present. Interestingly, comparing MRP8 and MRP14 promoter regions, we found several conserved motifs. These homologies suggest that the two promoters could be recognized by common factors that bind these sequence motifs. We now have a framework for future investigation involving the characterization of the regulatory mechanisms responsible for these effects.
Data indicate that MRP8 and MRP14 are involved in inflammatory reactions and that MRP8 is found in elevated levels in serum from cystic fibrosis patients. Since MRP8 and MRP14 are calcium-binding proteins and since calcium metabolism is likely to be deregulated in the salivary glands of cystic fibrosis patients (33) , it would be of interest to see whether the deregulation of these genes contributes to the etiology of this genetic defect.
